Browsing by Author "Atalar, B."
Now showing 1 - 12 of 12
- Results Per Page
- Sort Options
Item Clinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.(ELSEVIER IRELAND LTD, 2018-01-01) Atalar, B.; Sahin, B.; Mustafayev, T. Zoto; Gungor, G.; Aydin, G.; Yapici, B.; Ozyar, E.Item Correlation between PET/CT primary tumor FDG uptake and lymph node metastases in cervical cancer(ELSEVIER IRELAND LTD, 2017-01-01) Ugurluer, G.; Atalar, B.; Ikizler, H. A. Saran; Sozer, N.; Kibar, M.; Serin, M.; Ozyar, E.Item Dosimetric and Clinical Evaluation of Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Treatment of Adrenal Metastases(2021-01-01) Ugurluer, G.; Serkizyan, A.; Mustafayev, T. Zoto; Atalar, B.; Abacioglu, M. U.; Gungor, G.; Ozyar, E.Item Human-Level Precision Upper Abdominal OAR Contouring With Anatomically Preserving Deep Learning During Magnetic Resonance Imaging Guided Adaptive Radiotherapy (MRgRT)(2020-01-01) Gungor, G.; Michalet, M.; Lombard, A.; Roque, T.; Atalar, B.; Temur, B.; Serbez, I.; Azria, D.; De Vitry, L.; Riou, O.; Paragios, N.; Ozyar, E.; Fenoglietto, P.Item Metastases directed SBRT using Ga68-PSMA for oligometastatic prostate cancer: TROD 09-002 Study(ELSEVIER IRELAND LTD, 2019-01-01) Ozyigit, G.; Igdem, S.; Atalar, B.; Ozkok, H. B.; Hurmuz, P.; Akyol, F.Item Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART) With Median Biologically Effective Dose of 100 Gy10 for Oligometastases(2022-01-01) Chuong, M. D.; Herrera, R.; Mustafayev, T. Z.; Gungor, G.; Ugurluer, G.; Atalar, B.; Kotecha, R.; Hall, M. D.; Rubens, M.; Mittauer, K. E.; Contreras, J.; Gutierrez, A.; Kalman, N. S.; Alvarez, D.; Romaguera, T.; McCulloch, J.; Garcia, J.; Kaiser, A.; Mehta, M. P.; Ozyar, E.Item National, Observational, Multicentric Study in Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial(2019-01-01) Onal, C.; Demiral, A.; Atalar, B.; Yalman, D.; Gul, S.; Hurmuz, P.; Erpolat, P.; Akyurek, S.; Berber, T.; Guler, O.; Umay, C.; Sert, F.; Dagoglu, N.; Yaprak, G.; Karahacioglu, E.; Birgi, S. Duru; Saglam, E. KaytanItem Outcome and prognosticators in adult patients with medulloblastoma: a Rare Cancer Network study(ELSEVIER IRELAND LTD, 2016-01-01) Atalar, B.; Ozsahin, M.; Call, J.; Napieralska, A.; Kamer, S.; Salvador, V.; Erpolat, P.; Negretti, L.; Ramstad, Y. L.; Onal, C.; Akyurek, S.; Ugurluer, G.; Baumert, B.; Servagi-Vernat, S.; Miller, R. C.; Ozyar, E.; Sio, T.Item ROBOTIC STEREOTACTIC HYPOFRACTIONATED RADIOTHERAPY IN MENINGIOMAS(OXFORD UNIV PRESS INC, 2014-01-01) Sahin, B.; Atalar, B.; Aydin, G.; Gungor, G.; Yapici, B.; Ozyar, E.Item The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study(ELSEVIER IRELAND LTD, 2017-01-01) Ozyigit, G.; Onal, C.; Igdem, S.; Alicikus, Z. Arican; Iribas, A.; Akin, M.; Yalman, D.; Cetin, I.; Aksu, M. G.; Atalar, B.; Dincbas, F.; Aydin, B.; Sert, F.; Yildirim, C.; Gorken, I. B.; Agaoglu, F. Y.; Korcum, A. F.; Ozkok, S.; Darendeliler, E.; Akyol, F.Item Time Analysis in Magnetic Resonance Image-Guided Radiotherapy Workflow(2019-01-01) Mustafayev, T. Z.; Sahin, B.; Gungor, G.; Aydin, G.; Serbez, I.; Teymur, B.; Gur, G.; Arabaci, G.; Atalar, B.; Yapici, B.; Abacioglu, U.; Agaoglu, F.; Sengoz, M.; Ozyar, E.Item Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging(2019-01-01) Gultekin, M.; Guler, O. C.; Sari, S. Yuce; Yildirim, B. Akkus; Mustafayev, T. Z.; Atalar, B.; Bolukbasi, Y.; Onal, H. C.; Celik, H.; Yuce, K.; Ayhan, A.; Yildiz, F.